from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun A long-acting beta-adrenoceptor agonist drug (LABA) indicated for the treatment of chronic obstructive pulmonary disease.


from Wiktionary, Creative Commons Attribution/Share-Alike License



Help support Wordnik (and make this page ad-free) by adopting the word arformoterol.


  • Goodman believes that investors will increasingly return to Sepracor as its Lunesta sleep-aid continues its ramp in the face of new product launches, Xopenex franchise continues to grow, and arformoterol is approved by year-end 2006 or early 2007.

    Sepracor Shareholders Can Rest Easy After 'Excellent' Q4 2006

  • Approval for respiratory drug arformoterol could spark additional gains, the analyst added.

    Sepracor Gains Reflect Pfizer Buyout Speculation 2006

  • "We still believe that Sepracor is a good new product story with two products (Lunesta and Xopenex MDI) early in their life cycles and another product (arformoterol) expected to launch in 2007," the analyst added.

    Sepracor Shares Seen As Undervalued 2006

  • According to investigators, Medicare paid for 7 million units of the drug arformoterol, even though the manufacturer and the three largest wholesalers sold only 750,000 units in the area in 2008 and the first half of 2009. rss feed 2010

  • The spike in arformoterol only came after authorities tried to crack down on another inhaler drug, and illustrates a constant problem plaguing investigators. rss feed 2010

  • Fraudulent providers quickly realized they couldn't get as much money for that drug and began billing Medicare for arformoterol at rates exceeding the amount of drugs available. rss feed 2010

  • In fact, the high-dose arformoterol group showed somewhat greater reductions in rescue and supplemental medication use at six months than during the first few weeks of treatment. - medical news plus CME for physicians 2008

  • Steven Brown, M.D., a pulmonologist in Glendale, Wis., called the findings reassuring, especially in light of the black-box warning on arformoterol and all other products containing long-acting beta agonists. - medical news plus CME for physicians 2008

  • The values for arformoterol after six months were 0.24 L for the higher dose and 0.20 L for the lower dose, slightly lower than at the trial's start. - medical news plus CME for physicians 2008

  • BROVANA® brand arformoterol tartrate Inhalation Solution, OMNARIS ™ brand ciclesonide Nasal Spray and

    Medlogs - Recent stories 2008


Log in or sign up to get involved in the conversation. It's quick and easy.